Triple-negative breast cancer (TNBC) is a clinical aggressive subtype of breast cancer (BCa) that is defined by lack of estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER2) [1]. The gene discussed is ERBB2; the disease is breast carcinoma.